These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22736255)

  • 21. Biotherapy of cancer: break the barriers to foster translation of knowledge.
    Ferrantini M; Lombardo C; Moretti F; Belardelli F
    Tumori; 2008; 94(2):182-7. PubMed ID: 18564605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The future of targeting cytotoxic T-lymphocyte-associated protein-4: Is there a role?
    Di Giacomo AM; Lahn M; Eggermont AM; Fox B; Ibrahim R; Sharma P; Allison JP; Maio M
    Eur J Cancer; 2024 Feb; 198():113501. PubMed ID: 38169219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge 2018" (28-29 November, 2018, Naples, Italy).
    Ascierto PA; Bifulco C; Buonaguro L; Emens LA; Ferris RL; Fox BA; Delgoffe GM; Galon J; Gridelli C; Merlano M; Nathan P; Odunsi K; Okada H; Paulos CM; Pignata S; Schalper KA; Spranger S; Tortora G; Zarour H; Butterfield LH; Puzanov I
    J Immunother Cancer; 2019 Nov; 7(1):332. PubMed ID: 31783779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neoadjuvant immunotherapy is reshaping cancer management across multiple tumour types: The future is now!
    Maio M; Blank C; Necchi A; Di Giacomo AM; Ibrahim R; Lahn M; Fox BA; Bell RB; Tortora G; Eggermont AMM
    Eur J Cancer; 2021 Jul; 152():155-164. PubMed ID: 34107449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toward next-generation cancer immunotherapy: 10th annual meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 23-25, 2012.
    Kloke BP; Kutscher S; Rae R; Kvistborg P; Britten CM; Hadrup SR
    Cancer Immunol Immunother; 2013 May; 62(5):975-81. PubMed ID: 23299564
    [No Abstract]   [Full Text] [Related]  

  • 26. CIMT 2014: Next waves in cancer immunotherapy--report on the 12th annual meeting of the Association for Cancer Immunotherapy: May 6–8 2014, Mainz, Germany.
    Diken M; Boegel S; Grunwitz C; Kranz LM; Reuter K; van de Roemer N; Vascotto F; Vormehr M; Kreiter S
    Hum Vaccin Immunother; 2014; 10(10):3090-100. PubMed ID: 25483671
    [No Abstract]   [Full Text] [Related]  

  • 27. Toward the next waves of cancer immunotherapy: 11th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 14-16, 2013.
    Kloke BP; Rae R; Mahr A; Burkhardt UE; Kvistborg P; Britten CM
    Cancer Immunol Immunother; 2014 Jul; 63(7):749-55. PubMed ID: 24190545
    [No Abstract]   [Full Text] [Related]  

  • 28. Cancer immunotherapy achieves breakthrough status: 12th annual meeting of the association for cancer immunotherapy (CIMT), Mainz, Germany, May 6-8, 2014.
    Kloke BP; Mahr A; Jabulowsky RA; Kutscher S; Rae R; Britten CM
    Cancer Immunol Immunother; 2015 Jul; 64(7):923-30. PubMed ID: 25548093
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunotherapy at the American Association for Cancer Research 95th annual meeting: a personal impression.
    Guinn BA
    Cancer Immunol Immunother; 2005 Mar; 54(3):290-5. PubMed ID: 15372206
    [No Abstract]   [Full Text] [Related]  

  • 30. Mechanisms of efficacy in cancer immunotherapy: 14th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 10-12, 2016.
    Theelen J; Braun J; Hörzer H; Kloke BP; Ott M; Pizzitola I; Schirmer U; Miller M
    Cancer Immunol Immunother; 2017 May; 66(5):673-681. PubMed ID: 28251274
    [No Abstract]   [Full Text] [Related]  

  • 31. CIMT 2013: advancing targeted therapies--report on the 11th Annual Meeting of the Association for Cancer Immunotherapy, May 14-16 2013, Mainz, Germany.
    Diken M; Attig S; Grunwitz C; Kranz L; Simon P; van de Roemer N; Vascotto F; Kreiter S
    Hum Vaccin Immunother; 2013 Sep; 9(9):2025-32. PubMed ID: 23877042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proceedings of the 7th Annual Meeting of the Society of Biotherapeutic Approaches and the 2nd Annual Meeting of the Japan Research Association for Immunotherapeutics. December 7, 2003. Tokyo, Japan.
    Anticancer Res; 2004; 24(5C):3289-392. PubMed ID: 15529466
    [No Abstract]   [Full Text] [Related]  

  • 33. Proceedings of the joint meeting of the 8th Annual Meeting of the Society of Biotherapeutic Approaches and the 3rd Meeting of the Japan Research Association of Immunotherapeutics. December 4, 2004. Fukuoka, Japan.
    Anticancer Res; 2005; 25(6A):3679-776. PubMed ID: 16323359
    [No Abstract]   [Full Text] [Related]  

  • 34. Redefining cancer immunotherapy-optimization, personalization, and new predictive biomarkers: 4th Cancer Immunotherapy and Immunomonitoring (CITIM) meeting, April 27-30, 2015, Ljubljana, Slovenia.
    Aptsiauri N; Jewett A; Hurwitz AA; Shurin MR; Umansky V
    Cancer Immunol Immunother; 2016 Jul; 65(7):875-83. PubMed ID: 26810566
    [No Abstract]   [Full Text] [Related]  

  • 35. Recent advances in cancer immunotherapy with an emphasis on vaccines.
    Cavallo F; Forni G
    Expert Rev Vaccines; 2009 Jan; 8(1):25-8. PubMed ID: 19093768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Biotherapy of solid tumors].
    Moiseenko VM
    Vopr Onkol; 1998; 44(1):120-5. PubMed ID: 9578746
    [No Abstract]   [Full Text] [Related]  

  • 37. CIMT 2017: Anniversary symposium - Report on the 15th CIMT Annual Meeting of the Association for Cancer Immunotherapy.
    Kranz LM; Beck JD; Grunwitz C; Hotz C; Vormehr M; Diken M
    Hum Vaccin Immunother; 2017 Oct; 13(10):2272-2279. PubMed ID: 28846471
    [No Abstract]   [Full Text] [Related]  

  • 38. Biotherapy: enlisting the immune system in cancer treatment.
    Long SJ
    AACN Clin Issues; 1996 Aug; 7(3):370-7; quiz 461-3. PubMed ID: 8826399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy).
    Ascierto PA; Brugarolas J; Buonaguro L; Butterfield LH; Carbone D; Daniele B; Ferris R; Fox BA; Galon J; Gridelli C; Kaufman HL; Klebanoff CA; Melero I; Nathan P; Paulos CM; Ruella M; Sullivan R; Zarour H; Puzanov I
    J Immunother Cancer; 2018 Jul; 6(1):69. PubMed ID: 29996914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Report about the XVIIIth meeting of the Cancer Research Institute in its international cancer immunotherapy symposium series on October 6-8, 2010.
    Hockertz S
    Toxicology; 2011 Jan; 279(1-3):203-7. PubMed ID: 21204306
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.